Vanguard Group Inc Eye Point Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,794,516 shares of EYPT stock, worth $45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,794,516

Previous 3,802,646 0.21%

Holding current value

$45 Million

Previous $35.8 Million 46.77%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$9.01 - $14.19 $73,251 - $115,364	-8,130 Reduced 0.21%	3,794,516 $52.5 Million
Q2 2025 Aug 11, 2025	SELL	$4.13 - $10.54 $131,011 - $334,349	-31,722 Reduced 0.83%	3,802,646 $35.8 Million
Q1 2025 May 09, 2025	BUY	$5.42 - $9.22 $168,784 - $287,120	31,141 Added 0.82%	3,834,368 $20.8 Million
Q4 2024 Feb 11, 2025	BUY	$7.02 - $12.12 $5.3 Million - $9.15 Million	755,045 Added 24.77%	3,803,227 $28.3 Million
Q3 2024 Nov 13, 2024	BUY	$7.58 - $10.54 $2.07 Million - $2.89 Million	273,728 Added 9.87%	3,048,182 $24.4 Million

Q2 2024 Aug 13, 2024	BUY	$8.16 - $22.89 $3.09 Million - $8.66 Million	378,226 Added 15.78%	2,774,454 $24.1 Million
Q1 2024 May 10, 2024	BUY	$19.93 - $29.71 $7.22 Million - $10.8 Million	362,168 Added 17.81%	2,396,228 $49.5 Million
Q4 2023 Feb 14, 2024	BUY	$5.71 - $24.13 $3.39 Million - $14.3 Million	593,336 Added 41.18%	2,034,060 $47 Million
Q3 2023 Nov 14, 2023	BUY	$7.99 - $15.36 $299,513 - $575,784	37,486 Added 2.67%	1,440,724 $11.5 Million
Q2 2023 Aug 14, 2023	BUY	$3.03 - $9.0 $12,741 - $37,845	4,205 Added 0.3%	1,403,238 $12.2 Million
Q1 2023 May 15, 2023	BUY	$2.28 - $5.04 $7,859 - $17,372	3,447 Added 0.25%	1,399,033 $4.11 Million
Q4 2022 Feb 10, 2023	SELL	$2.37 - $7.2 $6,877 - $20,894	-2,902 Reduced 0.21%	1,395,586 $4.88 Million
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.12 $300,463 - $480,050	43,170 Added 3.19%	1,398,488 $11.1 Million
Q2 2022 Aug 12, 2022	BUY	$7.25 - $12.71 $888,248 - $1.56 Million	122,517 Added 9.94%	1,355,318 $10.7 Million
Q1 2022 May 13, 2022	BUY	$8.67 - $14.11 $380,014 - $618,455	43,831 Added 3.69%	1,232,801 $15 Million
Q4 2021 Feb 14, 2022	BUY	$10.18 - $18.4 $984,039 - $1.78 Million	96,664 Added 8.85%	1,188,970 $14.6 Million
Q3 2021 Nov 12, 2021	BUY	$7.51 - $11.72 $44,887 - $70,050	5,977 Added 0.55%	1,092,306 $11.4 Million
Q2 2021 Aug 13, 2021	BUY	$8.69 - $11.08 $9.44 Million - $12 Million	1,086,329 New	1,086,329 $9.77 Million

Others Institutions Holding EYPT

# of Institutions

167

Shares Held

68M

Call Options Held

421K

Put Options Held

401K

View Full List

About EyePoint Pharmaceuticals, Inc.

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $404M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

More about EYPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Eye Point Pharmaceuticals, Inc. Transaction History